Plant-based Medicago to be acquired by Mitsubishi Tanabe Pharma

Medicago has announced that it has agreed to be acquired by Japanese company Mitsubishi Tanabe Pharma Corp (MTPC). The Canadian biopharmaceutical company has been developing vaccines using virus-like particles (VLPs) extracted from tobacco plants, and recently announced positive pre-clinical data with its VLP vaccine candidate for H7N9 influenza. The deal would make Medicago a joint-venture firm of MTPC (60%) and …